Subscribe To
GRAY / Graybug Vision (GRAY) Stock Soars 35% on Strategic Review News
GRAY News
By Zacks Investment Research
June 29, 2022
Graybug (GRAY) to Review Strategic Alternatives, Stock Up
Graybug's (GRAY) board of directors is set to review strategic options focused on maximizing shareholder value, including a potential sale of the comp more_horizontal
By InvestorPlace
June 28, 2022
Graybug Vision (GRAY) Stock Soars 35% on Strategic Review News
Today, investors in Graybug Vision and GRAY stock are cheering an announced strategic review, which could see a sale of the company. The post Graybug more_horizontal
By GlobeNewsWire
February 3, 2022
Graybug to Participate in Three Upcoming Medical and Investor Conferences
BALTIMORE, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing tra more_horizontal
By GlobeNewsWire
February 3, 2022
Graybug to Participate in Three Upcoming Medical and Investor Conferences
BALTIMORE, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing tra more_horizontal
By GlobeNewsWire
February 3, 2022
Graybug to Participate in Three Upcoming Medical and Investor Conferences
BALTIMORE, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing tra more_horizontal